2024

• Lau, J., Fleming, J., Good, M., Lim, A., Saunderson, R., Phan, T., Schlub, T., Siow, S., Lacson, N., Romo, C., Berman, Y., et al (2024). Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1. Skin Research and Technology, 30(9), e70020. [More Information]
• Berry, M., Khan, S., Schlub, T., Notaras, A., Kunasekaran, M., Grulich, A., MacIntyre, C., Davenport, M., Khoury, D. (2024). Predicting vaccine effectiveness for mpox. Nature Communications, 15(1). [More Information]
• Lee, W., Amarasena, T., Esterbauer, R., Haycroft, E., Ramanathan, P., Davenport, M., Schlub, T., Sasadeusz, J., Wheatley, A., Chung, A., et al (2024). Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine. Journal of Clinical Investigation, 134(17), e181244. [More Information]
• Broadhead, G., Grigg, J., McCluskey, P., Hong, T., Schlub, T., Chu, E., Chang, A. (2024). Saffron therapy for the ongoing treatment of age-related macular degeneration. BMJ Open Ophthalmology, 9(1), e001399. [More Information]
• Hasan, T., Mirzayev, F., Morgan, H., Motta, I., Nguyen, L., Schumacher, S., Schlub, T., Fox, G., Medcalf, E., Nyang’wa, B., et al (2024). The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis. Clinical Infectious Diseases, 78(3), 730-741. [More Information]
• Morgan, H., Fox, G., Ndjeka, N., Hasan, T., Gegia, M., Mirzayev, F., Nguyen, L., Schumacher, S., Schlub, T., Naidoo, K. (2024). Treatment of Multidrug-resistant or Rifampicin-resistant Tuberculosis With an All-oral 9-month Regimen Containing Linezolid or Ethionamide in South Africa: A Retrospective Cohort Study. Clinical Infectious Diseases, 78(6), 1698-1706. [More Information]
• Elias, K., Khan, S., Stadler, E., Schlub, T., Cromer, D., Polizzotto, M., Kent, S., Turner, T., Davenport, M., Khoury, D. (2024). Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis. The Lancet Microbe, 5(5), e459-e467. [More Information]

2023

• Fleming, J., Morgan, O., Wong, C., Schlub, T., Berman, Y. (2023). Characterization of health concerns in people with neurofibromatosis type 1. Molecular Genetics & Genomic Medicine, 11(1). [More Information]
• Wilding, M., Fleming, J., Moore, K., Crook, A., Reddy, R., Choi, S., Schlub, T., Field, M., Thiyagarajan, L., Thompson, J., et al (2023). Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 1. Familial Cancer, 22, 499-511. [More Information]
• Khoury, D., Schlub, T., Cromer, D., Steain, M., Fong, Y., Gilbert, P., Subbarao, K., Triccas, J., Kent, S., Davenport, M. (2023). Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection. Emerging Infectious Diseases, 29(2), 381-388. [More Information]
• Stadler, E., Chai, K., Schlub, T., Cromer, D., Khan, S., Polizzotto, M., Kent, S., Beecher, C., White, H., Turner, T., et al (2023). Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis. The Lancet Microbe, 4(11), e883-e892. [More Information]
• Butow, P., Faris, M., Shaw, J., Kelly, P., He, S., Harris, M., Cuddy, J., Masya, L., Geerligs, L., Kelly, B., Rankin, N., Beale, P., Dhillon, H., Grimison, P., Clayton, J., Schlub, T., Shepherd, H., et al (2023). Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial. Implementation Science, 18(1), 18. [More Information]
• Stadler, E., Burgess, M., Schlub, T., Khan, S., Chai, K., McQuilten, Z., Wood, E., Polizzotto, M., Kent, S., Cromer, D., et al (2023). Monoclonal antibody levels and protection from COVID-19. Nature Communications, 14(1), 4545. [More Information]
• Cromer, D., Steain, M., Reynaldi, A., Schlub, T., Khan, S., Sasson, S., Kent, S., Khoury, D., Davenport, M. (2023). Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis. Nature Communications, 14(1). [More Information]
• Docken, S., Cromer, D., Keele, B., Paiardini, M., Betts, M., Bar, K., Davenport, M., McCormick, K., Pampena, M., Samer, S., Schlub, T., et al (2023). Preferential selection of viral escape mutants by CD8+ T cell 'sieving' of SIV reactivation from latency. PLoS Pathogens, 19(11), e1011755. [More Information]
• Fisher, K., Schlub, T., Boyer, Z., Rasmussen, T., Rhodes, A., Hoh, R., Hecht, F., Deeks, S., Lewin, S., Palmer, S. (2023). Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4. Frontiers in Immunology, 14. [More Information]

2022

• Napier, C., Davies, G., Butow, P., Schlub, T., Best, M., Bartley, N., Juraskova, I., Meiser, B., Tucker, K., Biesecker, B., et al (2022). Cancer patient knowledge about and behavioral intentions after germline genome sequencing. Patient Education and Counseling, 105(3), 707-718. [More Information]
• Horsburgh, B., Hiener, B., Fisher, K., Lee, E., Morgan, H., Eden, J., von Stockenstrom, S., Odevall, L., Milush, J., Hoh, R., Schlub, T., Palmer, S., et al (2022). Cellular Activation, Differentiation, and Proliferation Influence the Dynamics of Genetically Intact Proviruses over Time. The Journal of Infectious Diseases, 225(7), 1168-1178. [More Information]
• Cole, B., Lambrechts, L., Boyer, Z., Noppe, Y., De Scheerder, M., Eden, J., Vrancken, B., Schlub, T., McLaughlin, S., Frenkel, L., Palmer, S., et al (2022). Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption. Cell Reports, 39(4), 110739. [More Information]
• Wang, C., Julg, B., Schlub, T., Yu, W., Sabrina Tan, C., Stefic, K., Gianella, S., Smith, D., Lauffenburger, D., Chaillon, A. (2022). Landscape of Human Immunodeficiency Virus Neutralization Susceptibilities Across Tissue Reservoirs. Clinical Infectious Diseases, 75(8), 1342-1350. [More Information]
• Wang, X., Zerbato, J., Avihingsanon, A., Fisher, K., Schlub, T., Rhodes, A., Audsley, J., Singh, K., Zhao, W., Lewin, S., Palmer, S. (2022). Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals. Journal of Virology, 96(16). [More Information]
• Cromer, D., Steain, M., Reynaldi, A., Schlub, T., Wheatley, A., Juno, J., Kent, S., Triccas, J., Khoury, D., Davenport, M. (2022). Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis. The Lancet Microbe, 3(1), e52-e61. [More Information]
• Stadler, E., Cromer, D., Mehra, S., Adekunle, A., Flegg, J., Anstey, N., Watson, J., Chu, C., Mueller, I., Robinson, L., Schlub, T., et al (2022). Population heterogeneity in Plasmodium vivax relapse risk. PLoS Neglected Tropical Diseases, 16(12). [More Information]
• Best, M., Butow, P., Savard, J., Jacobs, C., Bartley, N., Davies, G., Napier, C., Ballinger, M., Thomas, D., Biesecker, B., Juraskova, I., Schlub, T., Newson, A., et al (2022). Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting. European Journal of Human Genetics, 30(8), 930-937. [More Information]
• Butow, P., Best, M., Davies, G., Schlub, T., Napier, C., Bartley, N., Ballinger, M., Juraskova, I., Meiser, B., Goldstein, D., et al (2022). Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients. Patient Education and Counseling, 105(7), 2206-2216. [More Information]
• Vatter, S., Schlub, T., Napier, C., Best, M., Bartley, N., Juraskova, I., Meiser, B., Ballinger, M., Biesecker, B., Goldstein, D., Butow, P., et al (2022). Psychological Outcomes in Advanced Cancer Patients After Receiving Genomic Tumor Profiling Results. Health Psychology, 41(6), 396-408. [More Information]
• Meiser, B., Butow, P., Davies, G., Napier, C., Schlub, T., Bartley, N., Juraskova, I., Ballinger, M., Thomas, D., Best, M., et al (2022). Psychological predictors of advanced cancer patients’ preferences for return of results from comprehensive tumor genomic profiling. American Journal of Medical Genetics, Part A, 188(3), 725-734. [More Information]
• Meiser, B., Butow, P., Davies, G., Napier, C., Schlub, T., Bartley, N., Juraskova, I., Ballinger, M., Thomas, D., Best, M. (2022). Psychological predictors of cancer patients' and their relatives' attitudes towards the return of genomic sequencing results. European Journal of Medical Genetics, 65(6), 104516. [More Information]
• Duette, G., Hiener, B., Morgan, H., Mazur, F., Mathivanan, V., Horsburgh, B., Fisher, K., Tong, O., Lee, E., Ahn, H., Nasr, N., Cunningham, A., Schlub, T., Palmer, S., et al (2022). The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells. Journal of Clinical Investigation, 132(7). [More Information]
• Best, M., Napier, C., Schlub, T., Bartley, N., Biesecker, B., Ballinger, M., Butow, P. (2022). Validation of the multidimensional impact of Cancer Risk Assessment Questionnaire to assess impact of waiting for genome sequencing results. Psycho-Oncology, 31(7), 1204-1211. [More Information]
• Butow, P., Davies, G., Napier, C., Bartley, N., Ballinger, M., Biesecker, B., Juraskova, I., Meiser, B., Schlub, T., Thomas, D., Best, M., et al (2022). Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study. Journal of Genetic Counseling, 31(1), 96-108. [More Information]

2021

• Bartley, N., Napier, C., Butt, Z., Schlub, T., Best, M., Ballinger, M., Biesecker, B., Butow, P. (2021). Cancer Patient Experience of Uncertainty While Waiting for Genome Sequencing Results. Frontiers in Psychology, 12, 647502. [More Information]
• Wheatley, A., Juno, J., Wang, J., Selva, K., Reynaldi, A., Tan, H., Lee, W., Wragg, K., Kelly, H., Esterbauer, R., Schlub, T., et al (2021). Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nature Communications, 12(1), 1162. [More Information]
• Bartley, N., Davies, G., Butow, P., Napier, C., Schlub, T., Ballinger, M., Thomas, D., Juraskova, I., Meiser, B., Best, M. (2021). Fear of cancer recurrence in patients undergoing germline genome sequencing. Supportive Care in Cancer, 29(12), 7289-7297. [More Information]
• Bacchus-Souffan, C., Fitch, M., Palmer, S., Schlub, T., Wang, X., Hiener, B., Horsburgh, B., Fisher, K., Morcilla, V., Hoh, R., et al (2021). HIV-1 Genomes Are Enriched in Memory CD4+ T-Cells with Short Half-Lives. mBio, 12(5), e02447-21. [More Information]
• Butow, P., Muller, F., Napier, C., Bartley, N., Ballinger, M., Biesecker, B., Juraskova, I., Meiser, B., Schlub, T., Thomas, D., Best, M., et al (2021). Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling. Psycho-Oncology, 30(11), 1920-1929. [More Information]
• Khoury, D., Cromer, D., Reynaldi, A., Schlub, T., Wheatley, A., Juno, J., Subbarao, K., Kent, S., Triccas, J., Davenport, M. (2021). Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine, 27(7), 1205-1211. [More Information]
• Moriarty, R., Fesser, N., Sutton, M., Venturi, V., Davenport, M., Schlub, T., O’Connor, S. (2021). Validation of multiplex PCR sequencing assay of SIV. Virology Journal, 18(1), 21. [More Information]

2020

• Davies, G., Butow, P., Napier, C., Bartley, N., Juraskova, I., Meiser, B., Ballinger, M., Thomas, D., Schlub, T., Best, M. (2020). Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling. Translational Oncology, 13(9), 1-9. [More Information]
• Best, M., Butow, P., Jacobs, C., Juraskova, I., Savard, J., Meiser, B., Goldstein, D., Ballinger, M., Bartley, N., Napier, C., Davies, G., Schlub, T., Newson, A., et al (2020). Advanced cancer patient preferences for receiving molecular profiling results. Psycho-Oncology, 29(10), 1533-1539. [More Information]
• Butow, P., Davies, G., Napier, C., Schlub, T., Best, M., Bartley, N., Juraskova, I., Meiser, B., Ballinger, M., Biesecker, B., et al (2020). Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer. JAMA Network Open, 3(5), 1-15. [More Information]
• Broadhead, G., Hong, T., Grigg, J., McCluskey, P., Schlub, T., Spooner, K., Chang, A. (2020). Does functional assessment predict everyday visual functioning? Visual function testing and quality of life in mild/moderate age-related macular degeneration. International Ophthalmology, 40(12), 3241-3249. [More Information]
• Kite, J., Schlub, T., Zhang, Y., Choi, S., Craske, S., Dickson, M. (2020). Exploring lecturer and student perceptions and use of a learning management system in a postgraduate public health environment. E-Learning and Digital Media, 17(3), 183-198. [More Information]
• Horsburgh, B., Lee, E., Hiener, B., Eden, J., Schlub, T., von Stockenstrom, S., Odevall, L., Milush, J., Liegler, T., Sinclair, E., Palmer, S., et al (2020). High levels of genetically intact HIV in HLA-DR+ memory T cells indicates their value for reservoir studies. AIDS, 34(5), 659-668. [More Information]
• Chaillon, A., Gianella, S., Dellicour, S., Rawlings, S., Schlub, T., de Oliveira, M., Ignacio, C., Porrachia, M., Vrancken, B., Smith, D. (2020). HIV persists throughout deep tissues with repopulation from multiple anatomical sources. Journal of Clinical Investigation, 130(4), 1699-1712. [More Information]
• Ju, Y., Kelly, H., Dagley, L., Reynaldi, A., Schlub, T., Spall, S., Bell, C., Cui, J., Mitchell, A., Lin, Z., et al (2020). Person-specific biomolecular coronas modulate nanoparticle interactions with immune cells in human blood. ACS Nano, 14(11), 15723-15737. [More Information]
• Schlub, T., Holmes, E. (2020). Properties and abundance of overlapping genes in viruses. Virus Evolution, 6(1), 1-8. [More Information]

2019

• Bahrami, B., Hong, T., Schlub, T., Chang, A. (2019). AFLIBERCEPT FOR PERSISTENT DIABETIC MACULAR EDEMA: Forty-Eight-Week Outcomes. Retina, 39(1), 61-68. [More Information]
• Deleage, C., Immonen, T., Fennessey, C., Reynaldi, A., Reid, C., Newman, L., Lipkey, L., Schlub, T., Camus, C., O'Brien, S., et al (2019). Defining early SIV replication and dissemination dynamics following vaginal transmission. Science Advances, 5(5), 1-15. [More Information]
• Reynaldi, A., Smith, N., Schlub, T., Tabilas, C., Venturi, V., Rudd, B., Davenport, M. (2019). Fate mapping reveals the age structure of the peripheral T cell compartment. Proceedings of the National Academy of Sciences of the United States of America, 116(10), 3974-3981. [More Information]
• De Scheerder, M., Vrancken, B., Dellicour, S., Schlub, T., Lee, E., Shao, W., Rutsaert, S., Verhofstede, C., Kerre, T., Malfait, T., Palmer, S., et al (2019). HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse Reservoirs. Cell Host and Microbe, 26(3), 347-358.e7. [More Information]
• Reynaldi, A., Dent, A., Schlub, T., Ogolla, S., Rochford, R., Davenport, M. (2019). Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants. Malaria Journal, 18(1), 1-9. [More Information]
• Marcelino, V., Wille, M., Hurt, A., Gonzalez-Acuna, D., Klaassen, M., Schlub, T., Eden, J., Shi, M., Iredell, J., Sorrell, T., Holmes, E. (2019). Meta-transcriptomics reveals a diverse antibiotic resistance gene pool in avian microbiomes. BMC Biology, 17(1), 1-11. [More Information]
• Best, M., Sleasman, M., Hegedus, E., Schlub, T. (2019). Protestant Christian attitudes to ART. Human Reproduction Open, 2019 (3), 1-7. [More Information]
• Broadhead, G., Grigg, J., McCluskey, P., Hong, T., Schlub, T., Chang, A. (2019). Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial. Graefe's Archive for Clinical and Experimental Ophthalmology, 257(1), 31-40. [More Information]

2018

• Schlub, T., Buchmann, J., Holmes, E. (2018). A simple method to detect candidate overlapping genes in viruses using single genome sequences. Molecular Biology and Evolution, 35(10), 2572-2581. [More Information]
• Winckelmann, A., Morcilla, V., Shao, W., Schleimann, M., Hojen, J., Schlub, T., Benton, P., Ostergaard, L., Sogaard, O., Tolstrup, M., Palmer, S. (2018). Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1 infected individuals. AIDS, 32(13), 1793-1802. [More Information]
• Shi, M., White, V., Schlub, T., Eden, J., Hoffman, A., Holmes, E. (2018). No detectable effect of Wolbachia wMel on the prevalence and abundance of the RNA virome of Drosophila melanogaster. Proceedings of the Royal Society B: Biological Sciences, 285(1883), 1-10. [More Information]
• Best, M., Newson, A., Meiser, B., Juraskova, I., Goldstein, D., Tucker, K., Ballinger, M., Hess, D., Schlub, T., Biesecker, B., Savard, J., Butow, P., et al (2018). The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling. BMC Cancer, 18(1), 389. [More Information]
• Best, M., Newson, A., Meiser, B., Juraskova, I., Goldstein, D., Tucker, K., Ballinger, M., Hess, D., Schlub, T., Biesecker, B., Savard, J., Butow, P., et al (2018). The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer. BMC Cancer, 18(1), 454. [More Information]

2017

• Broadhead, G., Hong, T., McCluskey, P., Grigg, J., Schlub, T., Chang, A. (2017). Choroidal Thickness and Microperimetry Sensitivity in Age-Related Macular Degeneration. Ophthalmic Research, 58(1), 27-34. [More Information]
• Di Giallonardo, F., Schlub, T., Shi, M., Holmes, E. (2017). Dinucleotide Composition in Animal RNA Viruses Is Shaped More by Virus Family than by Host Species. Journal of Virology, 91(8), 1-15. [More Information]
• Hiener, B., Horsburgh, B., Eden, J., Barton, K., Schlub, T., Lee, E., van Stockenstrom, S., Odevall, L., Milush, J., Liegler, T., Palmer, S., et al (2017). Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants. Cell Reports, 21(3), 813-822. [More Information]
• McBride, K., Ballinger, M., Schlub, T., Young, M., Tattersall, M., Kirk, J., Eeles, R., Killick, E., Walker, L., Shanley, S., et al (2017). Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? Familial Cancer, 16(3), 423-432. [More Information]
• Winckelmann, A., Barton, K., Hiener, B., Schlub, T., Shao, W., Rasmussen, T., Ostergaard, L., Sogaard, O., Tolstrup, M., Palmer, S. (2017). Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations. AIDS, 31(6), 771-779. [More Information]
• Bahrami, B., Hong, T., Zhu, M., Schlub, T., Chang, A. (2017). Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema. Graefe's Archive for Clinical and Experimental Ophthalmology, 255, 1133-1140. [More Information]

2016

• Harrison, P., Ooi, C., Schlub, T. (2016). An express sexual health service: In and out in a jiffy. Australian Health Review, 40(3), 273-276. [More Information]
• Santella, A., Schlub, T., Schifter, M., Tolani, M., Hillman, R. (2016). Australian dentists' perspectives on rapid HIV testing. Australian Dental Journal, 61(3), 270-276. [More Information]
• Santella, A., Schlub, T., Fagan, D., Hillman, R., Krass, I. (2016). Australian pharmacists' willingness to conduct rapid HIV testing in community pharmacies. Sexual Health, 13(3), 292-294. [More Information]
• Cromer, D., Grimm, A., Schlub, T., Mak, J., Davenport, M. (2016). Estimating the in-vivo HIV template switching and recombination rate. AIDS, 30(2), 185-192. [More Information]
• Cromer, D., Schlub, T., Smyth, R., Grimm, A., Chopra, A., Mallal, S., Davenport, M., Mak, J. (2016). HIV-1 Mutation and Recombination Rates Are Different in Macrophages and T-cells. Viruses, 8(4), 1-14. [More Information]
• McBride, K., Schlub, T., Ballinger, M., Thomas, D., Tattersall, M. (2016). International survey of awareness of genetic risk in the clinical sarcoma community. Asia-Pacific Journal of Clinical Oncology, 12(2), 133-142. [More Information]
• Chang, A., Broadhead, G., Hong, T., Joachim, N., Syed, A., Schlub, T., Toth, L., Peto, T., Zhu, M. (2016). Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes. Ophthalmic Research, 55(2), 84-90. [More Information]
• Reynaldi, A., Schlub, T., Piriou, E., Ogolla, S., Sumba, P., Moormann, A., Rochford, R., Davenport, M. (2016). Modeling of EBV infection and antibody responses in Kenyan infants with different levels of malaria exposure shows maternal antibody decay is a major determinant of early EBV infection. The Journal of Infectious Diseases, 214(9), 1390-1398. [More Information]
• Reynaldi, A., Smith, N., Schlub, T., Venturi, V., Rudd, B., Davenport, M. (2016). Modeling the dynamics of neonatal CD8+ T-cell responses. Immunology and Cell Biology, 94(9), 838-848. [More Information]
• Reynaldi, A., Schlub, T., Chelimo, K., Sumba, P., Piriou, E., Ogolla, S., Moormann, A., Rochford, R., Davenport, M. (2016). The impact of malaria co-infections on longitudinal Epstein-Barr virus kinetics in Kenyan children. The Journal of Infectious Diseases, 213(6), 985-991. [More Information]
• Cooke, G., Schlub, T., Sherwin, W., Ord, T. (2016). Understanding the Spatial Scale of Genetic Connectivity at Sea: Unique Insights from a Land Fish and a Meta-Analysis. PloS One, 11(5), 1-25. [More Information]
• Kothur, K., Wienholt, L., Mohammad, S., Tantsis, E., Pillai, S., Britton, P., Jones, C., Angiti, R., Barnes, E., Schlub, T., Brilot-Turville, F., Dale, R., et al (2016). Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis. PloS One, 11(8), 1-19. [More Information]

2015

• Broadhead, G., Hong, T., Zhu, M., Li, H., Schlub, T., Wijeyakumar, W., Chang, A. (2015). Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration. Retina, 35(5), 975-981. [More Information]
• Santella, A., Schlub, T., Ooi, C., Varma, R., Holt, M., Prestage, G., Hillman, R. (2015). Sexual behaviour and HIV prevention needs of men attending a suburban Sex on Premises Venue. Sexual Health, 12(5), 383-389. [More Information]
• Mahady, S., Schlub, T., Bero, L., Moher, D., Tovey, D., George, J., Craig, J. (2015). Side effects are incompletely reported among systematic reviews in gastroenterology. Journal of Clinical Epidemiology, 68(2), 144-153. [More Information]
• Ansari, N., Young, C., Schlub, T., Dhillon, H., Solomon, M. (2015). Understanding surgeon decision making in the use of radiotherapy as neoadjuvant treatment in rectal cancer. International Journal of Surgery, 24, 1-6. [More Information]

2014

• Cui, J., Schlub, T., Holmes, E. (2014). An allometric relationship between the genome length and virion volume of viruses. Journal of Virology, 88(11), 6403-6410. [More Information]
• Schlub, T., Grimm, A., Smyth, R., Cromer, D., Chopra, A., Mallal, S., Venturi, V., Waugh, C., Mak, J., Davenport, M. (2014). Fifteen to twenty percent of HIV substitution mutations are associated with recombination. Journal of Virology, 88(7), 3837-3849. [More Information]
• Smyth, R., Schlub, T., Grimm, A., Waugh, C., Ellenberg, P., Chopra, A., Mallal, S., Cromer, D., Mak, J., Davenport, M. (2014). Identifying Recombination Hot Spots in the HIV-1 Genome. Journal of Virology, 88(5), 2891-2902. [More Information]
• Chang, A., Li, H., Broadhead, G., Hong, T., Schlub, T., Wijeyakumar, W., Zhu, M. (2014). Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration. Ophthalmology, 121(1), 188-192. [More Information]

2011

• Schlub, T., Sun, J., Walton, S., Robbins, S., Pinto, A., Munks, M., Hill, A., Brossay, L., Oxenius, A., Davenport, M. (2011). Comparing the Kinetics of NK Cells, CD4, and CD8 T Cells in Murine Cytomegalovirus Infection. Journal of Immunology, 187(3), 1385-1392. [More Information]
• Paiardini, M., Cervasi, B., Reyes-Aviles, E., Micci, L., Ortiz, A., Chahroudi, A., Vinton, C., Gordon, S., Bosinger, S., Schlub, T., et al (2011). Low levels of SIV infection in sooty mangabey central memory CD4+ T cells are associated with limited CCR5 expression. Nature Medicine, 17(7), 830-836. [More Information]

2010

• Schlub, T., Smyth, R., Grimm, A., Mak, J., Davenport, M. (2010). Accurately measuring recombination between closely related HIV-1 genomes. PLoS Computational Biology, 6(4), e1000766. [More Information]
• Rajasuriar, R., Booth, D., Solomon, A., Chua, K., Spelman, T., Gouillou, M., Schlub, T., Davenport, M., Crowe, S., Elliot, J., Stewart, G., et al (2010). Biological Determinants of Immune Reconstitution in HIV-Infected Patients Receiving Antiretroviral Therapy: The Role of Interleukin 7 and Interleukin 7 Receptor alpha and Microbial Translocation. The Journal of Infectious Diseases, 202(8), 1254-1264. [More Information]
• Schlub, T., Badovinac, V., Sabel, J., Harty, J., Davenport, M. (2010). Predicting CD62L expression during the CD8+ T-cell response in vivo. Immunology and Cell Biology, 88(2), 157-164. [More Information]
• Smyth, R., Schlub, T., Grimm, A., Venturi, V., Chopra, A., Mallal, S., Davenport, M., Mak, J. (2010). Reducing chimera formation during PCR amplification to ensure accurate genotyping. Gene, 88, 157-164. [More Information]

2009

• Schlub, T., Venturi, V., Kedzierska, K., Wellard, C., Doherty, P., Turner, S., Ribeiro, R., Hodgkin, P., Davenport, M. (2009). Division-linked differentiation can account for CD8+ T-cell phenotype in vivo. European Journal of Immunology, 39(1), 67-77. [More Information]